At a glance
ClinicalIndex Comparison RecordN/ACompleted· 79 enrolled
Drug / intervention
Alpinia galanga formulation +3 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot, Randomized, Double-blind, Placebo-controlled, Parallel Design Study to Evaluate the Effectiveness and Safety of an Alpinia Galanga Formulation, Theacrine Formulation, and Caffeine Formulation on Fatigue, Mental Acuity, and Cognitive Health Among Overall Healthy Participants
In Brief
A clinical study evaluating Alpinia galanga formulation, Theacrine formulation, and 2 other interventions for Fatigue. Completed, enrolled 79 participants across 1 site.
Detailed Summary
The purpose of this study is to assess the effectiveness and safety of the Alpinia galanga formulation, Theacrine formulation, and Caffeine formulation on fatigue, mental acuity, and cognitive health among overall healthy participants
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFatigue
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartNov 2021
First PostedDec 2021
Primary CompletionMay 2022
TodayJul 2026
First PostedDec 27, 2021
Enrollment StartNov 2, 2021
Primary CompletionMay 31, 2022
TodayJul 1, 2026
Enrollment to primary: 7 monthsPosted 4.5 years ago
Interventions
Alpinia galanga formulationdietary
Alpinia galanga formulation capsule- 1 capsule daily
Theacrine formulationdietary
Theacrine formulation capsule- 1 capsule daily
Caffeine formulationdietary
Caffeine formulation capsule- I capsule daily
Placebodietary
Placebo capsule- 1 capsule daily